hims fda warning letter compounded semaglutide 2025 and Novo Nordisk Warned of GLP-1 Telehealth Compounding Takedown. What's Next? Lawmakers request FDA review Hims

Hair shedding during GLP-1 therapy can be distressing, but research shows hair typically regrows once your body stabilizes after rapid weight loss

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system

Metabolic health is highly dependent on intestinal and hepatic handling of dietary and endogenous lipids and lipoproteins

Recent Findings Newer generation GLP-1 based therapies have become more effective for the treatment of overweight and obesity, with data supporting tirzepatide as the most effective, followed by semaglutide and then liraglutide

Product amount: 29.77 oz./844g